Talkspace, Inc. (TALK)
USD 3.09
(-5.21%)
USD 3.09
(-5.21%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -22.01 Million USD | 68.34% |
| 2022 | -78.06 Million USD | 24.38% |
| 2021 | -84.55 Million USD | -325.64% |
| 2020 | -21.6 Million USD | 26.44% |
| 2019 | -29.36 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -3.26 Million USD | -135.86% |
| 2024 Q1 | -1.47 Million USD | 35.74% |
| 2024 Q3 | 373.59 Thousand USD | 102.84% |
| 2023 Q2 | -6.1 Million USD | 30.08% |
| 2023 Q1 | -8.73 Million USD | 0.34% |
| 2023 FY | - USD | 68.34% |
| 2023 Q4 | -2.3 Million USD | 52.81% |
| 2023 Q3 | -4.87 Million USD | 20.18% |
| 2022 Q2 | -20.8 Million USD | -0.1% |
| 2022 Q1 | -20.77 Million USD | 27.29% |
| 2022 FY | - USD | 24.38% |
| 2022 Q4 | -8.76 Million USD | 55.16% |
| 2022 Q3 | -19.54 Million USD | 6.05% |
| 2021 Q1 | -12.09 Million USD | -13.19% |
| 2021 FY | - USD | -325.64% |
| 2021 Q4 | -28.57 Million USD | -15.59% |
| 2021 Q3 | -24.72 Million USD | 8.66% |
| 2021 Q2 | -27.06 Million USD | -123.79% |
| 2020 Q3 | -2.38 Million USD | -272.07% |
| 2020 FY | - USD | 26.44% |
| 2020 Q4 | -10.68 Million USD | -348.05% |
| 2020 Q2 | -641 Thousand USD | -64000.0% |
| 2020 Q1 | -1000.00 USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 189.11 Million USD | 111.64% |
| Addus HomeCare Corporation | 106.55 Million USD | 120.658% |
| AirSculpt Technologies, Inc. | 28.31 Million USD | 177.751% |
| Amedisys, Inc. | 216.91 Million USD | 110.148% |
| American Oncology Network, Inc. | -39.35 Million USD | 44.06% |
| Astrana Health, Inc. | 123.68 Million USD | 117.797% |
| Aveanna Healthcare Holdings Inc. | 44.34 Million USD | 149.637% |
| IMAC Holdings, Inc. | -5.94 Million USD | -270.166% |
| biote Corp. | 9.23 Million USD | 338.391% |
| Cryo-Cell International, Inc. | -10.41 Million USD | -111.312% |
| Cross Country Healthcare, Inc. | 129.33 Million USD | 117.02% |
| COMPASS Pathways plc | -123.8 Million USD | 82.219% |
| DocGo Inc. | 32.72 Million USD | 167.266% |
| The Ensign Group, Inc. | 353.23 Million USD | 106.232% |
| Healthcare Services Group, Inc. | 75.21 Million USD | 129.268% |
| InnovAge Holding Corp. | 1.15 Million USD | 2007.539% |
| Assure Holdings Corp. | -19.82 Million USD | -11.042% |
| The Joint Corp. | 9.14 Million USD | 340.797% |
| LifeStance Health Group, Inc. | -104.92 Million USD | 79.02% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.55 Million USD | -41.52% |
| ModivCare Inc. | -26.75 Million USD | 17.708% |
| NewGenIvf Group Limited | 384.3 Thousand USD | 5828.002% |
| Novo Integrated Sciences, Inc. | -5.84 Million USD | -276.355% |
| Option Care Health, Inc. | 376.79 Million USD | 105.842% |
| P3 Health Partners Inc. | -81.07 Million USD | 72.847% |
| P3 Health Partners Inc. | -81.07 Million USD | 72.847% |
| The Pennant Group, Inc. | 30.36 Million USD | 172.485% |
| Surgery Partners, Inc. | 446.1 Million USD | 104.935% |
| Syra Health Corp. Class A Common Stock | -2.83 Million USD | -676.23% |
| Talkspace, Inc. | -22.01 Million USD | -0.0% |
| The Oncology Institute, Inc. | -70.45 Million USD | 68.756% |
| The Oncology Institute, Inc. | -70.45 Million USD | 68.756% |